Cargando…

The Efficacy and Safety of Mizoribine versus Mycophenolate Mofetil for the Treatment of Renal Transplantation: A Systematic Review and Meta-Analysis

BACKGROUND: Mizoribine (MZR) is widely used in Asia due to its high safety and low cost, and comparative studies of its safety and efficacy with the first-line drug mycophenolate mofetil (MMF) have been carried out. This paper aimed to compare the efficacy and safety of MZR and MMF in immunosuppress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jie, Liu, Hua, Yin, Wenjun, Xu, Zhengguang, Chen, Zekai, Yiu, Wingkeung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337967/ https://www.ncbi.nlm.nih.gov/pubmed/35909831 http://dx.doi.org/10.1155/2022/5717068

Ejemplares similares

Comparative efficacy and safety of mizoribine and mycophenolate mofetil for treating systemic lupus erythematosus: a retrospective cohort study
por: Ayano, Masahiro, et al.
Publicado: (2022)

Mycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection
por: Dalal, Pranav, et al.
Publicado: (2009)

A four-drug combination therapy consisting of low-dose tacrolimus, low-dose mycophenolate mofetil, corticosteroids, and mizoribine in living donor renal transplantation: A randomized study
por: Yan, Tian-zhong, et al.
Publicado: (2016)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Efficacy and Safety of an Everolimus- vs. a Mycophenolate Mofetil-Based Regimen in Pediatric Renal Transplant Recipients
por: Brunkhorst, Lena Caroline, et al.
Publicado: (2015)

Effect of Mycophenolate Mofetil on Plasma Bioelements in Renal Transplant Recipients
por: Kamińska, Jolanta, et al.
Publicado: (2011)

The Influence of Mycophenolate Mofetil and Azathioprine on the Same Cadaveric Donor Renal Transplantation
por: Joh, Jae Won, et al.
Publicado: (2005)

Efficacy and safety of a reduced calcineurin inhibitor dose combined with mycophenolate mofetil in liver transplant patients with chronic renal dysfunction
por: Wang, Pusen, et al.
Publicado: (2017)

Conversion from mycophenolate mofetil to mizoribine in the early stages of BK polyomavirus infection could improve kidney allograft prognosis: a single-center study from China
por: Li, Ping, et al.
Publicado: (2021)

Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2011)

Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis
por: Nambiar, Anoop M., et al.
Publicado: (2017)

Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review
por: Chen, Youyuan, et al.
Publicado: (2014)

The efficacy of Mycophenolate mofetil for the treatment of Chinese Takayasu’s arteritis
por: Li, Jing, et al.
Publicado: (2016)

Mycophenolate-mofetil/prednisone: Lack of efficacy: case report
Publicado: (2021)

Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
por: Kim, Hyeyoung, et al.
Publicado: (2014)

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome
por: Dorresteijn, Eiske M., et al.
Publicado: (2008)

Efficacy and safety of mycophenolate mofetil in the treatment of moderate to severe Graves’ orbitopathy: a meta-analysis
por: Feng, Wenwen, et al.
Publicado: (2022)

Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysis
por: Du, Bing, et al.
Publicado: (2017)

Comparative Efficacy and Safety of Mycophenolate Mofetil and Azathioprine in Combination with Corticosteroids in the Treatment of Lymphocytic Myocarditis
por: Blagova, Olga, et al.
Publicado: (2023)

Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)

Severe Enteropathy From Mycophenolate Mofetil
por: Jehangir, Asad, et al.
Publicado: (2016)

Autoimmune Gastritis Treated With Mycophenolate Mofetil
por: Harb, Ali H., et al.
Publicado: (2020)

Mycophenolate mofetil: Cytopenia: case report
Publicado: (2021)

Mycophenolate mofetil in giant cell arteritis
por: Pankow, Anne, et al.
Publicado: (2023)

Serum Selenium, Iron, Zinc, and Copper Concentrations in Renal Transplant Recipients Treated with Mycophenolate Mofetil
por: Wilk, Aleksandra, et al.
Publicado: (2020)

Efficacy and tolerability of mycophenolate mofetil in a pediatric Rasmussen syndrome()
por: Orsini, A., et al.
Publicado: (2019)

Efficacy and safety of a conversion from the original tacrolimus and mycophenolate mofetil to the generics Tacpan(®) and Mowel(®) after liver transplantation
por: Vollmar, Johanna, et al.
Publicado: (2015)

Acute pancreatitis induced by mycophenolate mofetil in a kidney transplant patient
por: Einollahi, Behzad, et al.
Publicado: (2015)

Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease
por: Jones, Rachel B., et al.
Publicado: (2014)

Mycophenolate-mofetil/mycophenolic-acid: COVID-19: 4 case reports
Publicado: (2021)

Population pharmacokinetics of mycophenolate mofetil in pediatric patients early after liver transplantation
por: Wei, Yinyi, et al.
Publicado: (2022)

Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders
por: Sheikhzadeh, Sanaz, et al.
Publicado: (2013)

Differential profiles of adverse events associated with mycophenolate mofetil between adult and pediatric renal transplant patients
por: Hosohata, Keiko, et al.
Publicado: (2018)

Impact of Fasting Status and Circadian Variation on the Pharmacokinetics of Mycophenolate Mofetil and the Glucuronide Metabolite in Renal Transplant Recipients
por: Drevland, Ole Martin, et al.
Publicado: (2023)

The Efficacy of Adjuvant Targeted Therapy in Patients with Advanced Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Yiu, Wingkeung, et al.
Publicado: (2022)

Comparative efficacy and safety of mycophenolate mofetil and cyclophosphamide in the induction treatment of lupus nephritis: A systematic review and meta-analysis
por: Jiang, Yue-Peng, et al.
Publicado: (2020)

Mycophenolate mofetil (MMF) treatment efficacy in children with primary and secondary glomerulonephritis
por: Ostalska-Nowicka, Danuta, et al.
Publicado: (2011)

Efficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis
por: Rezaieyazdi, Zahra, et al.
Publicado: (2014)

MANAGEMENT OF ERYTHEMA NODOSUM LEPROSUM BY MYCOPHENOLATE MOFETIL
por: Banerjee, Kalyan, et al.
Publicado: (2008)

Perforated Jejunal Diverticulum in the Use of Mycophenolate Mofetil
por: Thongprayoon, Charat, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dem6i691cj3qhgrtbckvu765s9